Novel biomarkers for the prediction of metastasis in colorectal cancer

By Zlobec Inti  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 2, 2013-03 ,pp. : 137-146

Informa Healthcare

Access to resources Recommend Favorite

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

By Simon Richard  

Personalized Medicine, Vol. 7, Iss. 1, 2010-01 ,pp. : 33-47

Future Medicine

Access to resources Recommend Favorite

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The Gunma Clinical Oncology Group (GCOG) trial 001 SILK Study

By  

Oncology, Vol. 83, Iss. 3, 2012-08 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer

By  

Oncology, Vol. 90, Iss. 2, 2016-0 ,pp. : 59-68

Karger

Access to resources Recommend Favorite

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer

By Gyparaki Melina-Theoni   Basdra Efthimia   Papavassiliou Athanasios  

Journal of Molecular Medicine, Vol. 91, Iss. 11, 2013-11 ,pp. : 1249-1256

Springer Publishing Company

Access to resources Recommend Favorite